ENTITY
Jafron Biomedical

Jafron Biomedical (300529 CH)

32
Analysis
Health Care • China
Jafron Biomedical Co., Ltd. manufactures biomaterials and medical devices. The Company researches, produces, and sells immunization adsorption, resin hemoperfusion, blood purification, resin bandage, and other related products. Jafron Biomedical markets throughout China.
more
•16 Jan 2026 14:29

Quiddity Leaderboard ChiNext & ChiNext 50 Jun26: ~US$1.86bn Combined One-Way Flow; Ranks Can Change

We see US$1.86bn in combined one-way flow for the ChiNext and ChiNext 50 June 2025 index rebal events. With more time left in the reference period,...

Share
•16 Aug 2026 10:15

A-Share Margin Trading Weekly (Aug 14th): SHANGHAI GENTECH, TCL, JIANGSU HENGRUI MEDICINE, CSSC

We analyzed A-share margin trading positions report for the past week and highlighted SHANGHAI GENTECH, TCL, JIANGSU HENGRUI MEDICINE, CSSC, CMOC.

Logo
108 Views
Share
•12 Jun 2026 12:47

Quiddity CSI 1000 Jun26 Results: 84% Correctly Predicted; ~US$1.2bn One-Way Flow

The CSI 1000 ADDs are up nearly 7% against the the CSI 1000 DELs from 2nd June 2026 to 11th June 2026 going by the naming convention used in this...

Share
•08 May 2026 14:45

Quiddity Leaderboard CSI 1000 Jun26: Ad Hoc Changes Announced; Final Expectations Post-Adjustment

The CSI 1000 index could see US$1.6bn one-way flows during the June 2026 index rebal event. The ADDs/DELs could be confirmed after market close on...

Share
bullish•QuantumCTek
•22 Apr 2026 19:25

Quiddity Leaderboard CSI 1000 Jun26: Strong Outperformance of Net Inflows Vs Net Outflows

On aggregate, the 100 CSI 1000 Expected ADDs and DELs could see ~US$1.49bn index buying and ~US$1.5bn index selling related to the CSI 1000 index.

Share
x